WEST PHARM.SVCS DL-,25/ US9553061055 /
8/28/2024 9:42:53 PM | Chg. -3.700 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
265.400EUR | -1.37% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 19.3 bill.EUR | - | - |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 711.7000 | 705.8000 | 721 | 778.3000 | 855 | ||||||
Intangible Assets | 48.3000 | 42 | 37.6000 | 23.3000 | 21.7000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 1,011.6000 | 1,021.4000 | 1,074.8000 | 1,119.3000 | ||||||
Inventories | 176.9000 | 181.5000 | 181.1000 | 199.3000 | 215.2000 | ||||||
Accounts Receivable | 185.7000 | 179 | 181.4000 | 200.5000 | 253.2000 | ||||||
Cash and Cash Equivalents | 230 | 255.3000 | 274.6000 | 203 | 235.9000 | ||||||
Current Assets | 650.7000 | 659.3000 | 673.7000 | 641.9000 | 743.5000 | ||||||
Total Assets | 1,671.6000 | 1,670.9000 | 1,695.1000 | 1,716.7000 | 1,862.8000 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 108 | 103.1000 | 119.8000 | 122 | 138.1000 | ||||||
Long-term debt | - | 309.5000 | 228.9000 | 226.2000 | 197 | ||||||
Liabilities to Banks | 2.2000 | 27.2000 | 69.3000 | 2.4000 | 0.0000 | ||||||
Provisions | 26.7000 | 30.6000 | 25.2000 | 13.7000 | 16.4000 | ||||||
Liabilities | 765.2000 | 714 | 671.2000 | 599.2000 | 582.9000 | ||||||
Share Capital | 17.6000 | 17.8000 | 18.1000 | 18.4000 | 18.8000 | ||||||
Total Equity | 906.4000 | 956.9000 | 1,023.9000 | 1,117.5000 | 1,279.9000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,671.6000 | 1,670.9000 | 1,695.1000 | 1,716.7000 | 1,862.8000 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,368.4000 | 1,368.4000 | 1,399.8000 | 1,509.1000 | 1,599.1000 | ||||||
Depreciation (total) | - | 81 | 86.1000 | - | - | ||||||
Operating Result | 162.4000 | 162.4000 | 128.6000 | 196.8000 | 228.9000 | ||||||
Interest Income | -15.1000 | 17 | 14.1000 | 8.1000 | 7.8000 | ||||||
Income Before Taxes | 147.1000 | 147.1000 | 116.1000 | 189.8000 | 222.4000 | ||||||
Income Taxes | 40.2000 | 40.2000 | 26.3000 | 54.4000 | 80.9000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 112.3000 | 112.3000 | 95.6000 | 143.6000 | 150.7000 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 220.5000 | 220.5000 | 212.4000 | 219.4000 | 263.3000 | ||||||
Cash Flow from Investing Activities | -149.9000 | -149.9000 | -129.5000 | -175.8000 | -133.6000 | ||||||
Cash Flow from Financing | -5.1000 | -5.1000 | -41.5000 | -113.9000 | -109 | ||||||
Decrease / Increase in Cash | 68.1000 | 68.1000 | 19.3000 | -71.6000 | 32.9000 | ||||||
Employees | 6,900 | 7,000 | 7,100 | 7,300 | 7,500 |